Tiameko Overton
Women's Health · Lafayette, LANPI 1962492249
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations.
Across 53 payments — averaging $39.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$447
- Astellas Pharma US Inc$223
- Avion Pharmaceuticals$220
- Alkermes, Inc.$125
- AstraZeneca$122
- Ardelyx, Inc.$115
- plus $856 from 15 others
What the payments were for
- Food & beverage$2,108100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $447 |
| Astellas Pharma US Inc | 2 | $223 |
| Avion Pharmaceuticals | 1 | $220 |
| Alkermes, Inc. | 8 | $125 |
| AstraZeneca | 1 | $122 |
| Ardelyx, Inc. | 1 | $115 |
| Johnson & Johnson | 1 | $102 |
| Teleflex LLC | 1 | $94 |
| Evofem Biosciences, Inc. | 2 | $91 |
| Vanda Pharmaceuticals Inc. | 4 | $87 |
| Novo Nordisk | 1 | $79 |
| Boehringer Ingelheim | 1 | $76 |
| Pfizer | 4 | $75 |
| Coloplast | 1 | $74 |
| Lilly USA, LLC | 1 | $55 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Abbott | 1 | $25 |
| Millicent US Inc | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Amgen | 1 | $14 |
| Exeltis, USA Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,108 in reported general payments places this provider in the 80th percentile of 128 women's health providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 36 | $2,442 |
| Clobetasol Propionate | 14 | $401 |
| Alendronate Sodium | 67 | $239 |
| Metronidazole | 43 | $236 |
| Fluconazole | 28 | $112 |
| Oxybutynin Chloride | 15 | $76 |
| Buspirone Hcl | 13 | $32 |
Paid to pharmacies, not to this prescriber.
Other women's health in Lafayette
- Aundria CannonLafayette$5K
- Jordan ForsthoffLafayette$5K
- Jesti BreauxLafayette$2K
- Hannah RickettLafayette$624
- Amanda HayesShreveport$51K
- Nancy WellsBossier City$47K
- Ann JoplingMonroe$16K
- Kendra Joseph-RodgersNew Orleans$10K
- Jennifer MillerMonroe$4K
- Alysha HinsonShreveport$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.